CVR Medical Corp.
CVR Medical Corp. CRRVF Peers
See (CRRVF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CRRVF | $0.00 | N/A | 1.54M | N/A | -$0.03 | N/A |
| SEMHF | $55.28 | +2.37% | 62.00B | 26.58 | $2.08 | +2.02% |
| SMMNY | $27.64 | -0.41% | 62.00B | 26.58 | $1.04 | +1.21% |
| RYLPF | $24.21 | +0.01% | 22.40B | 83.49 | $0.29 | +3.89% |
| SONVF | $340.94 | N/A | 20.32B | 31.77 | $10.73 | +1.70% |
| SONVY | $67.72 | -0.52% | 20.25B | 31.50 | $2.15 | +1.41% |
| SNNUF | $14.21 | -4.25% | 12.43B | 30.23 | $0.47 | +2.64% |
| CHEOY | $88.66 | -1.17% | 11.60B | 48.98 | $1.81 | +1.59% |
| CHEOF | $175.40 | +3.18% | 11.44B | 48.19 | $3.64 | +1.58% |
| WILYY | $19.25 | N/A | 8.42B | 19.25 | $1.00 | N/A |
Stock Comparison
CRRVF vs SEMHF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, SEMHF has a market cap of 62.00B. Regarding current trading prices, CRRVF is priced at $0.00, while SEMHF trades at $55.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas SEMHF's P/E ratio is 26.58. In terms of profitability, CRRVF's ROE is +0.00%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, CRRVF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs SMMNY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, SMMNY has a market cap of 62.00B. Regarding current trading prices, CRRVF is priced at $0.00, while SMMNY trades at $27.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas SMMNY's P/E ratio is 26.58. In terms of profitability, CRRVF's ROE is +0.00%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, CRRVF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs RYLPF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, RYLPF has a market cap of 22.40B. Regarding current trading prices, CRRVF is priced at $0.00, while RYLPF trades at $24.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas RYLPF's P/E ratio is 83.49. In terms of profitability, CRRVF's ROE is +0.00%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, CRRVF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs SONVF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, SONVF has a market cap of 20.32B. Regarding current trading prices, CRRVF is priced at $0.00, while SONVF trades at $340.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas SONVF's P/E ratio is 31.77. In terms of profitability, CRRVF's ROE is +0.00%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, CRRVF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs SONVY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, SONVY has a market cap of 20.25B. Regarding current trading prices, CRRVF is priced at $0.00, while SONVY trades at $67.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas SONVY's P/E ratio is 31.50. In terms of profitability, CRRVF's ROE is +0.00%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, CRRVF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs SNNUF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, SNNUF has a market cap of 12.43B. Regarding current trading prices, CRRVF is priced at $0.00, while SNNUF trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas SNNUF's P/E ratio is 30.23. In terms of profitability, CRRVF's ROE is +0.00%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, CRRVF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs CHEOY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, CHEOY has a market cap of 11.60B. Regarding current trading prices, CRRVF is priced at $0.00, while CHEOY trades at $88.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas CHEOY's P/E ratio is 48.98. In terms of profitability, CRRVF's ROE is +0.00%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, CRRVF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs CHEOF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, CHEOF has a market cap of 11.44B. Regarding current trading prices, CRRVF is priced at $0.00, while CHEOF trades at $175.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas CHEOF's P/E ratio is 48.19. In terms of profitability, CRRVF's ROE is +0.00%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, CRRVF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs WILYY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, WILYY has a market cap of 8.42B. Regarding current trading prices, CRRVF is priced at $0.00, while WILYY trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas WILYY's P/E ratio is 19.25. In terms of profitability, CRRVF's ROE is +0.00%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, CRRVF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs WILLF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, WILLF has a market cap of 7.86B. Regarding current trading prices, CRRVF is priced at $0.00, while WILLF trades at $38.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas WILLF's P/E ratio is 19.11. In terms of profitability, CRRVF's ROE is +0.00%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, CRRVF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs GNGBY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, GNGBY has a market cap of 5.48B. Regarding current trading prices, CRRVF is priced at $0.00, while GNGBY trades at $20.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas GNGBY's P/E ratio is 35.76. In terms of profitability, CRRVF's ROE is +0.00%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, CRRVF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs GNGBF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, CRRVF is priced at $0.00, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, CRRVF's ROE is +0.00%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, CRRVF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs AMBBY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, AMBBY has a market cap of 4.20B. Regarding current trading prices, CRRVF is priced at $0.00, while AMBBY trades at $15.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas AMBBY's P/E ratio is 75.05. In terms of profitability, CRRVF's ROE is +0.00%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, CRRVF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs AMBFF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, AMBFF has a market cap of 4.02B. Regarding current trading prices, CRRVF is priced at $0.00, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, CRRVF's ROE is +0.00%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, CRRVF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs NHNKY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, NHNKY has a market cap of 3.96B. Regarding current trading prices, CRRVF is priced at $0.00, while NHNKY trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas NHNKY's P/E ratio is 20.75. In terms of profitability, CRRVF's ROE is +0.00%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, CRRVF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs NHNKF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, NHNKF has a market cap of 2.46B. Regarding current trading prices, CRRVF is priced at $0.00, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, CRRVF's ROE is +0.00%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, CRRVF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs VTRLY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, CRRVF is priced at $0.00, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, CRRVF's ROE is +0.00%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, CRRVF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs STSEY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, CRRVF is priced at $0.00, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas STSEY's P/E ratio is 39.41. In terms of profitability, CRRVF's ROE is +0.00%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, CRRVF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs GNNDY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, GNNDY has a market cap of 2.02B. Regarding current trading prices, CRRVF is priced at $0.00, while GNNDY trades at $41.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas GNNDY's P/E ratio is 16.81. In terms of profitability, CRRVF's ROE is +0.00%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, CRRVF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs GGNDF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, GGNDF has a market cap of 1.89B. Regarding current trading prices, CRRVF is priced at $0.00, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas GGNDF's P/E ratio is 15.66. In terms of profitability, CRRVF's ROE is +0.00%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, CRRVF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs OSSFF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, CRRVF is priced at $0.00, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, CRRVF's ROE is +0.00%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, CRRVF is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs DWRKF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, CRRVF is priced at $0.00, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, CRRVF's ROE is +0.00%, compared to DWRKF's ROE of N/A. Regarding short-term risk, CRRVF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs SSII Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, SSII has a market cap of 1.74B. Regarding current trading prices, CRRVF is priced at $0.00, while SSII trades at $8.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas SSII's P/E ratio is -112.12. In terms of profitability, CRRVF's ROE is +0.00%, compared to SSII's ROE of -1.33%. Regarding short-term risk, CRRVF is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs MCRPF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, CRRVF is priced at $0.00, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, CRRVF's ROE is +0.00%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, CRRVF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs OSSUY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, CRRVF is priced at $0.00, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, CRRVF's ROE is +0.00%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, CRRVF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs MEDGF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, CRRVF is priced at $0.00, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, CRRVF's ROE is +0.00%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, CRRVF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs DRWKF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, DRWKF has a market cap of 1.20B. Regarding current trading prices, CRRVF is priced at $0.00, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas DRWKF's P/E ratio is 9.10. In terms of profitability, CRRVF's ROE is +0.00%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, CRRVF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs DGWPF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, DGWPF has a market cap of 1.18B. Regarding current trading prices, CRRVF is priced at $0.00, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas DGWPF's P/E ratio is 7.72. In terms of profitability, CRRVF's ROE is +0.00%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, CRRVF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs XVIPF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, CRRVF is priced at $0.00, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas XVIPF's P/E ratio is 74.77. In terms of profitability, CRRVF's ROE is +0.00%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, CRRVF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs LFTSF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, CRRVF is priced at $0.00, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, CRRVF's ROE is +0.00%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, CRRVF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs ELEAF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, ELEAF has a market cap of 832.49M. Regarding current trading prices, CRRVF is priced at $0.00, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas ELEAF's P/E ratio is 12.22. In terms of profitability, CRRVF's ROE is +0.00%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, CRRVF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs MDRSF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, CRRVF is priced at $0.00, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, CRRVF's ROE is +0.00%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, CRRVF is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs CALZF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, CALZF has a market cap of 615.54M. Regarding current trading prices, CRRVF is priced at $0.00, while CALZF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas CALZF's P/E ratio is 89.10. In terms of profitability, CRRVF's ROE is +0.00%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, CRRVF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs AVMR Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, CRRVF is priced at $0.00, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas AVMR's P/E ratio is -18.34. In terms of profitability, CRRVF's ROE is +0.00%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, CRRVF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs CLVSF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, CRRVF is priced at $0.00, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, CRRVF's ROE is +0.00%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, CRRVF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs IOBCF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, IOBCF has a market cap of 388.16M. Regarding current trading prices, CRRVF is priced at $0.00, while IOBCF trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas IOBCF's P/E ratio is 37.86. In terms of profitability, CRRVF's ROE is +0.00%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, CRRVF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs HYBT Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, CRRVF is priced at $0.00, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas HYBT's P/E ratio is N/A. In terms of profitability, CRRVF's ROE is +0.00%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, CRRVF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs EAPIF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, CRRVF is priced at $0.00, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas EAPIF's P/E ratio is -1.98. In terms of profitability, CRRVF's ROE is +0.00%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, CRRVF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs CSSPF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, CRRVF is priced at $0.00, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, CRRVF's ROE is +0.00%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, CRRVF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs CYBQY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, CYBQY has a market cap of 258.06M. Regarding current trading prices, CRRVF is priced at $0.00, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas CYBQY's P/E ratio is -40.67. In terms of profitability, CRRVF's ROE is +0.00%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, CRRVF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs SNWV Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, SNWV has a market cap of 257.44M. Regarding current trading prices, CRRVF is priced at $0.00, while SNWV trades at $30.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas SNWV's P/E ratio is -4.83. In terms of profitability, CRRVF's ROE is +0.00%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, CRRVF is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs CLLKF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, CLLKF has a market cap of 253.16M. Regarding current trading prices, CRRVF is priced at $0.00, while CLLKF trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas CLLKF's P/E ratio is -8.14. In terms of profitability, CRRVF's ROE is +0.00%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, CRRVF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs HTLZF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, CRRVF is priced at $0.00, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, CRRVF's ROE is +0.00%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, CRRVF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs BCCOY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, BCCOY has a market cap of 221.04M. Regarding current trading prices, CRRVF is priced at $0.00, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, CRRVF's ROE is +0.00%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, CRRVF is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs IMPZY Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, CRRVF is priced at $0.00, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, CRRVF's ROE is +0.00%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, CRRVF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs AVHHL Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, AVHHL has a market cap of 176.38M. Regarding current trading prices, CRRVF is priced at $0.00, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, CRRVF's ROE is +0.00%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, CRRVF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs CYBQF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, CRRVF is priced at $0.00, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas CYBQF's P/E ratio is -43.33. In terms of profitability, CRRVF's ROE is +0.00%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, CRRVF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs BRNHF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, CRRVF is priced at $0.00, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, CRRVF's ROE is +0.00%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, CRRVF is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs EKDHF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, EKDHF has a market cap of 161.81M. Regarding current trading prices, CRRVF is priced at $0.00, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, CRRVF's ROE is +0.00%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, CRRVF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs JMDMF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, JMDMF has a market cap of 151.31M. Regarding current trading prices, CRRVF is priced at $0.00, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, CRRVF's ROE is +0.00%, compared to JMDMF's ROE of N/A. Regarding short-term risk, CRRVF is more volatile compared to JMDMF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs PXMBF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, PXMBF has a market cap of 142.82M. Regarding current trading prices, CRRVF is priced at $0.00, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, CRRVF's ROE is +0.00%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, CRRVF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs BRSYF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, CRRVF is priced at $0.00, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, CRRVF's ROE is +0.00%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, CRRVF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs AMEUF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, CRRVF is priced at $0.00, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, CRRVF's ROE is +0.00%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, CRRVF is more volatile compared to AMEUF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs VMTHF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, CRRVF is priced at $0.00, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, CRRVF's ROE is +0.00%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, CRRVF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs FDMDF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, CRRVF is priced at $0.00, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, CRRVF's ROE is +0.00%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, CRRVF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs RSHUF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, CRRVF is priced at $0.00, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, CRRVF's ROE is +0.00%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, CRRVF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs CKMTF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, CRRVF is priced at $0.00, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, CRRVF's ROE is +0.00%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, CRRVF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs SOMNF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, CRRVF is priced at $0.00, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, CRRVF's ROE is +0.00%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, CRRVF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs DMTRF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, CRRVF is priced at $0.00, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, CRRVF's ROE is +0.00%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, CRRVF is more volatile compared to DMTRF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs IPDQF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, IPDQF has a market cap of 75.83M. Regarding current trading prices, CRRVF is priced at $0.00, while IPDQF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas IPDQF's P/E ratio is -3.74. In terms of profitability, CRRVF's ROE is +0.00%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, CRRVF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs SNZZF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, CRRVF is priced at $0.00, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, CRRVF's ROE is +0.00%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, CRRVF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs RDGL Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, RDGL has a market cap of 56.12M. Regarding current trading prices, CRRVF is priced at $0.00, while RDGL trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas RDGL's P/E ratio is -12.37. In terms of profitability, CRRVF's ROE is +0.00%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, CRRVF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs BLOZF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, BLOZF has a market cap of 49.51M. Regarding current trading prices, CRRVF is priced at $0.00, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas BLOZF's P/E ratio is -21.50. In terms of profitability, CRRVF's ROE is +0.00%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, CRRVF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs NVYTF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, CRRVF is priced at $0.00, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas NVYTF's P/E ratio is -0.78. In terms of profitability, CRRVF's ROE is +0.00%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, CRRVF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs TLTFF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, TLTFF has a market cap of 32.14M. Regarding current trading prices, CRRVF is priced at $0.00, while TLTFF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas TLTFF's P/E ratio is -12.97. In terms of profitability, CRRVF's ROE is +0.00%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, CRRVF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs ELXMF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, CRRVF is priced at $0.00, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, CRRVF's ROE is +0.00%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, CRRVF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs PYNKF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, PYNKF has a market cap of 28.32M. Regarding current trading prices, CRRVF is priced at $0.00, while PYNKF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas PYNKF's P/E ratio is -1.68. In terms of profitability, CRRVF's ROE is +0.00%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, CRRVF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs KBBTF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, CRRVF is priced at $0.00, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, CRRVF's ROE is +0.00%, compared to KBBTF's ROE of N/A. Regarding short-term risk, CRRVF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs EMITF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, CRRVF is priced at $0.00, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas EMITF's P/E ratio is -15.38. In terms of profitability, CRRVF's ROE is +0.00%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, CRRVF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs POSC Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, POSC has a market cap of 21.16M. Regarding current trading prices, CRRVF is priced at $0.00, while POSC trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas POSC's P/E ratio is 0.44. In terms of profitability, CRRVF's ROE is +0.00%, compared to POSC's ROE of +9.25%. Regarding short-term risk, CRRVF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs ASAPF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, ASAPF has a market cap of 18.06M. Regarding current trading prices, CRRVF is priced at $0.00, while ASAPF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas ASAPF's P/E ratio is -23.39. In terms of profitability, CRRVF's ROE is +0.00%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, CRRVF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs VPTDF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, VPTDF has a market cap of 14.46M. Regarding current trading prices, CRRVF is priced at $0.00, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas VPTDF's P/E ratio is -4.43. In terms of profitability, CRRVF's ROE is +0.00%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, CRRVF is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs MDXHF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, MDXHF has a market cap of 14.31M. Regarding current trading prices, CRRVF is priced at $0.00, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, CRRVF's ROE is +0.00%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, CRRVF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs TMDIF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, TMDIF has a market cap of 13.91M. Regarding current trading prices, CRRVF is priced at $0.00, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, CRRVF's ROE is +0.00%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, CRRVF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs DIZTF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, DIZTF has a market cap of 13.69M. Regarding current trading prices, CRRVF is priced at $0.00, while DIZTF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas DIZTF's P/E ratio is -5.67. In terms of profitability, CRRVF's ROE is +0.00%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, CRRVF is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs PLLWF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, CRRVF is priced at $0.00, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, CRRVF's ROE is +0.00%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, CRRVF is more volatile compared to PLLWF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs RMSL Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, RMSL has a market cap of 12.28M. Regarding current trading prices, CRRVF is priced at $0.00, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas RMSL's P/E ratio is 0.80. In terms of profitability, CRRVF's ROE is +0.00%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, CRRVF is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs IMEXF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, IMEXF has a market cap of 11.62M. Regarding current trading prices, CRRVF is priced at $0.00, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas IMEXF's P/E ratio is N/A. In terms of profitability, CRRVF's ROE is +0.00%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, CRRVF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs ATBPF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, CRRVF is priced at $0.00, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, CRRVF's ROE is +0.00%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, CRRVF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs LXXGF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, CRRVF is priced at $0.00, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, CRRVF's ROE is +0.00%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, CRRVF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs GTHP Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, GTHP has a market cap of 9.86M. Regarding current trading prices, CRRVF is priced at $0.00, while GTHP trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas GTHP's P/E ratio is -2.50. In terms of profitability, CRRVF's ROE is +0.00%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, CRRVF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs IRME Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, IRME has a market cap of 8.64M. Regarding current trading prices, CRRVF is priced at $0.00, while IRME trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas IRME's P/E ratio is -4.00. In terms of profitability, CRRVF's ROE is +0.00%, compared to IRME's ROE of +11.77%. Regarding short-term risk, CRRVF is more volatile compared to IRME. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs MKEAF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, MKEAF has a market cap of 6.43M. Regarding current trading prices, CRRVF is priced at $0.00, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, CRRVF's ROE is +0.00%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, CRRVF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs DTXMF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, CRRVF is priced at $0.00, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, CRRVF's ROE is +0.00%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, CRRVF is more volatile compared to DTXMF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs TBRIF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, TBRIF has a market cap of 5.64M. Regarding current trading prices, CRRVF is priced at $0.00, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas TBRIF's P/E ratio is -1.24. In terms of profitability, CRRVF's ROE is +0.00%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, CRRVF is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs QLIS Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, CRRVF is priced at $0.00, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas QLIS's P/E ratio is 2.22. In terms of profitability, CRRVF's ROE is +0.00%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, CRRVF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs RHNMF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, CRRVF is priced at $0.00, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, CRRVF's ROE is +0.00%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, CRRVF is more volatile compared to RHNMF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs MICR Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, CRRVF is priced at $0.00, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas MICR's P/E ratio is -3.47. In terms of profitability, CRRVF's ROE is +0.00%, compared to MICR's ROE of -0.25%. Regarding short-term risk, CRRVF is more volatile compared to MICR. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs FZMD Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, FZMD has a market cap of 4.43M. Regarding current trading prices, CRRVF is priced at $0.00, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas FZMD's P/E ratio is 1.20. In terms of profitability, CRRVF's ROE is +0.00%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, CRRVF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs NUMD Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, NUMD has a market cap of 4.18M. Regarding current trading prices, CRRVF is priced at $0.00, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas NUMD's P/E ratio is 5.00. In terms of profitability, CRRVF's ROE is +0.00%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, CRRVF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs LBLTF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, CRRVF is priced at $0.00, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, CRRVF's ROE is +0.00%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, CRRVF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs ADMT Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, ADMT has a market cap of 4.06M. Regarding current trading prices, CRRVF is priced at $0.00, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas ADMT's P/E ratio is -6.00. In terms of profitability, CRRVF's ROE is +0.00%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, CRRVF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs VYCO Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, VYCO has a market cap of 4.00M. Regarding current trading prices, CRRVF is priced at $0.00, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas VYCO's P/E ratio is -12.00. In terms of profitability, CRRVF's ROE is +0.00%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, CRRVF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs ALRTF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, ALRTF has a market cap of 3.81M. Regarding current trading prices, CRRVF is priced at $0.00, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas ALRTF's P/E ratio is -0.20. In terms of profitability, CRRVF's ROE is +0.00%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, CRRVF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs VANIW Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, CRRVF is priced at $0.00, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas VANIW's P/E ratio is N/A. In terms of profitability, CRRVF's ROE is +0.00%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, CRRVF is more volatile compared to VANIW. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs ESMC Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, ESMC has a market cap of 3.34M. Regarding current trading prices, CRRVF is priced at $0.00, while ESMC trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas ESMC's P/E ratio is 45.00. In terms of profitability, CRRVF's ROE is +0.00%, compared to ESMC's ROE of +0.47%. Regarding short-term risk, CRRVF is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs USAQ Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, USAQ has a market cap of 2.93M. Regarding current trading prices, CRRVF is priced at $0.00, while USAQ trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas USAQ's P/E ratio is -8.67. In terms of profitability, CRRVF's ROE is +0.00%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, CRRVF is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs BIEL Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, BIEL has a market cap of 2.71M. Regarding current trading prices, CRRVF is priced at $0.00, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas BIEL's P/E ratio is N/A. In terms of profitability, CRRVF's ROE is +0.00%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, CRRVF is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.
CRRVF vs PMEDF Comparison
CRRVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRRVF stands at 1.54M. In comparison, PMEDF has a market cap of 2.25M. Regarding current trading prices, CRRVF is priced at $0.00, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRRVF currently has a P/E ratio of N/A, whereas PMEDF's P/E ratio is -1.50. In terms of profitability, CRRVF's ROE is +0.00%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, CRRVF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for CRRVF.